A detailed history of Everence Capital Management Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Everence Capital Management Inc holds 15,770 shares of BLFS stock, worth $428,313. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,770
Previous 15,770 -0.0%
Holding current value
$428,313
Previous $277,000 42.6%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 16, 2023

BUY
$10.81 - $22.96 $170,473 - $362,079
15,770 New
15,770 $218,000
Q1 2022

Apr 11, 2022

SELL
$20.81 - $37.29 $151,080 - $270,725
-7,260 Closed
0 $0
Q4 2021

Jan 28, 2022

BUY
$32.99 - $58.55 $239,507 - $425,073
7,260 New
7,260 $271,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.16B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Everence Capital Management Inc Portfolio

Follow Everence Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.